Stephen Saad’s Aspen to pioneer South Africa’s first human insulin production
Established in 1997 by Saad, Aspen has steadily expanded its global presence in the pharmaceutical sector.
Skip to content
Established in 1997 by Saad, Aspen has steadily expanded its global presence in the pharmaceutical sector.
Aspen Pharmacare, founded by Saad in 1997, has steadily fortified its global presence in the pharmaceutical sector for over two decades.
Saad, who founded Aspen Pharmacare Holdings in 1997, owns a 12.5-percent stake in the branded pharmaceutical company.
Aspen Pharmacare is a branded pharmaceutical company.
Saad’s stake in Aspen Pharma has fallen by $29 million as investors factor in the challenging operating conditions in the pharmaceutical industry.
With a net worth of $1.2 billion, Saad’s 12.5-percent stake in Aspen Pharmacare accounts for a significant portion of his wealth.
Meet seven African entrepreneurs who founded pharma companies worth at least $50 million.
Aspen Pharmacare Holdings is a South African multinational pharmaceutical holding company.
Aspen Pharmacare Holdings Limited is a South African multinational pharmaceutical holding company.
Attridge owns a 4.26-percent stake in the company.
Aspen Pharmacare is a multinational pharmaceutical holding company.
Aspen Pharmacare Holdings Limited is a South African multinational pharmaceutical holding company.
Saad owns a 12.5-percent stake in Aspen worth $566 million.
Saad owns a 12.5-percent stake in Aspen Pharmacare Holdings, worth $566 million.
Saad controls a 12.5-percent stake in the leading drug company.
The vaccine will be marketed as Aspenovax.